Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a
- PMID: 3028610
Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a
Abstract
Activated ras oncogene transfection into suitable recipient cells has been shown to induce the metastatic phenotype (Thorgeirsson, et al., Mol. Cell. Biol., 5: 259-262, 1985). We have used this model system to study the correlation of basement membrane collagenolysis with metastatic propensity. The c-Ha-ras oncogene alone, or combined with v-myc, transfected into early passage rat embryo fibroblasts, induce these cells to secrete high levels of type IV collagenolytic metalloproteinase and to concomitantly exhibit a high incidence of spontaneous metastases in nude mice. Cotransfection of c-Ha-ras plus the adenovirus type 2 E1a gene yields cells which are highly tumorigenic but nonmetastatic and fail to produce type IV collagenase. This effect is due to a suppression of collagenase elaboration, not increased production of a collagenase inhibitor, and not decreased production of a collagenase activator. The characteristics of the collagenase are identical to tumor type IV collagenase described previously. The nonmetastatic cells which failed to produce type IV collagenase retain the ability to secrete high levels of plasminogen activator. Transfection with the protooncogenic forms of Ha-ras or mos, or spontaneous transformation of NIH 3T3 cells or chemical transformation of BALB 3T3 cells yields cells which fail to produce collagenase, are tumorigenic, but totally nonmetastatic. These data support a biochemical linkage of type IV collagenase expression with the metastatic phenotype in this rodent system.
Similar articles
-
Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.Oncogene. 1993 May;8(5):1211-9. Oncogene. 1993. PMID: 8479744
-
Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.Oncogene. 1988 Feb;2(2):141-7. Oncogene. 1988. PMID: 3285293
-
Modulation of the transformed and neoplastic phenotype of rat fibroblasts by MHC-I gene expression.Cancer Res. 1989 Jun 15;49(12):3392-5. Cancer Res. 1989. PMID: 2655894
-
Role of the Ha-ras (RasH) oncogene in mediating progression of the tumor cell phenotype (review).Anticancer Res. 1990 May-Jun;10(3):717-24. Anticancer Res. 1990. PMID: 2195986 Review.
-
Search for metastasis suppressor genes.Invasion Metastasis. 1989;9(6):351-9. Invasion Metastasis. 1989. PMID: 2532185 Review.
Cited by
-
Gene products which play a role in cancer invasion and metastasis.Breast Cancer Res Treat. 1988 May;11(2):113-24. doi: 10.1007/BF01805835. Breast Cancer Res Treat. 1988. PMID: 3042051 Review.
-
The role of proteolytic enzymes in cancer invasion and metastasis.Clin Exp Metastasis. 1992 May;10(3):145-55. doi: 10.1007/BF00132746. Clin Exp Metastasis. 1992. PMID: 1582084 Review.
-
Loss of basal cell phenotype with acquisition of lung-colonizing capability in mouse mammary tumors.Breast Cancer Res Treat. 1991 Jan-Feb;17(3):239-43. doi: 10.1007/BF01806373. Breast Cancer Res Treat. 1991. PMID: 1710155
-
Cell-matrix interactions during tumor invasion.Cancer Metastasis Rev. 1990 Sep;9(2):113-23. doi: 10.1007/BF00046338. Cancer Metastasis Rev. 1990. PMID: 2253311 Review.
-
The in vitro assessment of dipyridophenazine complexes in H-ras oncogene transformed rat embryo fibroblast 5RP7 cell line.Invest New Drugs. 2018 Oct;36(5):755-762. doi: 10.1007/s10637-017-0559-4. Epub 2018 Jan 8. Invest New Drugs. 2018. PMID: 29313280
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials